TY - JOUR
T1 - Exercise capacity and ventilatory response during exercise in COPD patients with and without β blockade
AU - Thirapatarapong, Wilawan
AU - Armstrong, Hilary F.
AU - Bartels, Matthew N.
N1 - Funding Information:
This work was supported by the VIDDA Foundation.
PY - 2013/10
Y1 - 2013/10
N2 - Background: Although β blockade (BB) in patients with chronic obstructive pulmonary disease (COPD) does not show signs of worsening pulmonary function or respiratory symptoms, the effects on cardiopulmonary exercise testing (CPET) remain unclear. The aim of this study was to determine whether BB affects exercise capacity, gas exchange, and hemodynamic responses in patients with COPD. Methods: Twenty-four COPD subjects on BB were matched to 24 COPD subjects without BB according to age, gender, body mass index, and severity of COPD. All subjects underwent resting pulmonary function and symptom-limited CPET. Results: Comparing COPD patients with and without BB revealed that percent peak oxygen consumption and VE/VCO2 nadir were not significantly different (45 ± 16 vs. 51 ± 23 %, p = 0.30, and 35.1 ± 8.5 vs. 36.2 ± 11.6 %, p = 0.69). Systolic blood pressure and heart rate at peak exercise were significantly decreased in COPD patients with BB (168 ± 16 vs. 185 ± 20 mmHg, and 109 ± 16 vs. 122 ± 14 bpm, respectively, p < 0.05). Conclusion: Exercise capacity and gas exchange remain unaffected in patients with COPD in the presence of BB, although heart rate and blood pressure are lower. These findings imply that BB does not adversely affect functional capacity in patients with COPD.
AB - Background: Although β blockade (BB) in patients with chronic obstructive pulmonary disease (COPD) does not show signs of worsening pulmonary function or respiratory symptoms, the effects on cardiopulmonary exercise testing (CPET) remain unclear. The aim of this study was to determine whether BB affects exercise capacity, gas exchange, and hemodynamic responses in patients with COPD. Methods: Twenty-four COPD subjects on BB were matched to 24 COPD subjects without BB according to age, gender, body mass index, and severity of COPD. All subjects underwent resting pulmonary function and symptom-limited CPET. Results: Comparing COPD patients with and without BB revealed that percent peak oxygen consumption and VE/VCO2 nadir were not significantly different (45 ± 16 vs. 51 ± 23 %, p = 0.30, and 35.1 ± 8.5 vs. 36.2 ± 11.6 %, p = 0.69). Systolic blood pressure and heart rate at peak exercise were significantly decreased in COPD patients with BB (168 ± 16 vs. 185 ± 20 mmHg, and 109 ± 16 vs. 122 ± 14 bpm, respectively, p < 0.05). Conclusion: Exercise capacity and gas exchange remain unaffected in patients with COPD in the presence of BB, although heart rate and blood pressure are lower. These findings imply that BB does not adversely affect functional capacity in patients with COPD.
KW - COPD
KW - Exercise capacity
KW - Exercise test
KW - Gas exchange
KW - β Blocker
UR - http://www.scopus.com/inward/record.url?scp=84884819629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884819629&partnerID=8YFLogxK
U2 - 10.1007/s00408-013-9492-2
DO - 10.1007/s00408-013-9492-2
M3 - Article
C2 - 23877368
AN - SCOPUS:84884819629
SN - 0341-2040
VL - 191
SP - 531
EP - 536
JO - Lung
JF - Lung
IS - 5
ER -